Could institutional investors put the kibosh on the $74B Bristol-Celgene deal?
Source: https://ift.tt/2EFgqcH
Two major shareholders in BMS – Wellington Management and Starboard Value – said they would not support the deal and saw it as poorly thought out.
Source: https://ift.tt/2EFgqcH
0 Comments